Biosino Bio-Technology and Science Incorporation provided consolidated earnings guidance for the year ended 31 December 2016. The company is expected to record a substantial increase of approximately 3.8 times in net profit for the year ended 31 December 2016 as compared to the net profit of approximately RMB 2.1 million for the year ended 31 December 2015. The board considers that the substantial increase in net profit for the year ended 31 December 2016 was mainly attributable to the increase in overall revenue as a result of the growth of the business of the group; and the decrease in the selling and management expenses as a result of the internal restructuring and effective cost and expenses control conducted during the year.